Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer

IMPORTANCE: Neoadjuvant therapy is increasingly used in localized pancreatic carcinoma, and survival is correlated with carbohydrate antigen 19-9 (CA19-9) levels and histopathologic response following neoadjuvant therapy. With several regimens now available, the choice of chemotherapy could be best...

Descripción completa

Detalles Bibliográficos
Autores principales: AlMasri, Samer, Zenati, Mazen, Hammad, Abdulrahman, Nassour, Ibrahim, Liu, Hao, Hogg, Melissa E., Zeh, Herbert J., Boone, Brian, Bahary, Nathan, Singhi, Aatur D., Lee, Kenneth K., Paniccia, Alessandro, Zureikat, Amer H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227002/
https://www.ncbi.nlm.nih.gov/pubmed/35737385
http://dx.doi.org/10.1001/jamanetworkopen.2022.18355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227002/
https://www.ncbi.nlm.nih.gov/pubmed/35737385
http://dx.doi.org/10.1001/jamanetworkopen.2022.18355

Ejemplares similares